it’s a good step in the right direction however if this is basically just a cough counter there’s no reason they can’t broaden their product offerings by being a fart counter to detect bowel cancer
Ann: AstraZeneca to use new ResApp software in clinical study, page-48
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #